Rigel Pharmaceuticals RIGL Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's investment purchases?
- Rigel Pharmaceuticals (RIGL) reported investment purchases of $23.92M in Q1 2026.
- How has Rigel Pharmaceuticals's investment purchases changed year-over-year?
- Rigel Pharmaceuticals's investment purchases increased by 10.5% year-over-year, from $21.65M to $23.92M.
- What is the long-term trend for Rigel Pharmaceuticals's investment purchases?
- Over 3 years (2021 to 2025), Rigel Pharmaceuticals's investment purchases has grown at a 2.8% compound annual growth rate (CAGR), from $141.46M to $153.49M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.